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Abstract. To achieve and sustain malaria elimination, identiﬁcation and treatment of the asymptomatic infectious
reservoir is critical. Malaria rapid diagnostic tests (RDTs) are frequently used to identify asymptomatic, Plasmodium-
infected individuals through test-and-treat strategies, but their sensitivity is low when used in low transmission settings.
Characteristics of individuals with subpatent (RDT-negative but polymerase chain reaction [PCR]–positive) Plasmodium
parasitemia were evaluated in southern Zambia where malaria transmission has declined and efforts to achieve malaria
elimination are underway. Simple random sampling based on satellite imagery was used to select households for par-
ticipation in community-based, cross-sectional surveys between 2008 and 2013. Questionnaires were administered to
collect information on age, gender, recent history of malaria symptoms, and recent antimalarial drug use. Blood samples
were collected by ﬁnger prick for Plasmodium falciparum histidine-rich protein 2 RDT, blood smears for microscopy, and
dried blood spots for molecular analysis to detect malaria parasites and their sexual stage. Of 3,863 participants with
complete data, 102 (2.6%) were positive by microscopy, RDT, or PCR. Of these, 48 (47%) had subpatent parasitemia.
Most individuals with subpatent parasitemia were asymptomatic (85%). Compared with individuals without parasitemia,
individuals with subpatent parasitemia were signiﬁcantly more likely to be aged 5–25 years. Approximately one quarter
(27%) of those with subpatent parasitemia had detectable gametocytemia. These ﬁndings suggest that strategies based
on active or reactive case detection can identify asymptomatic individuals positive by RDT, butmore sensitive diagnostic
tests or focal drug administration may be necessary to target individuals with subpatent parasitemia to achieve malaria
elimination.
INTRODUCTION
As a result of increased funding and international commit-
ment supporting control interventions, malaria incidence
worldwide fell by 37% between 2000 and 2015.1 Over the
same period, malaria mortality fell by 60% in all age groups
and by 65% in children younger than 5 years.1 These epide-
miological trends were primarily driven by the scale-up of
insecticide-treated nets and indoor residual spraying, as well
as early diagnosis by rapiddiagnostic tests (RDTs) andprompt
treatment with artemisinin combination therapy (ACT).2 After
2015, the Global Technical Strategy for Malaria set ambitious
global targets for 2030: to reduce malaria incidence and
mortality rates by at least 90%, eliminate malaria from at least
35 countries, and prevent the re-establishment of local
transmission in malaria-free areas.2 Many countries have
made remarkable progress in reducing malaria morbidity and
mortality and are shifting their focus from malaria control to
elimination.
To achieve and sustain malaria elimination, timely identiﬁ-
cation, and treatment of both symptomatic and asymptomatic
infected individuals is critical. Passive case detection at health
facilities misses asymptomatic individuals who do not seek
medical care.3,4 Infected individuals without clinical signs and
symptoms can harbor gametocytes and serve as reservoirs
for transmission.5–7 The proportion of individuals harboring
malaria parasites who are asymptomatic varies depending on
transmission intensity and levels of clinical immunity.6 In high
transmission settings, asymptomatic malaria infections are
typically observed in older individuals with premunition fol-
lowing repeated parasite exposure. As transmission declines,
the proportion of asymptomatic, infected individuals may in-
crease until clinical immunity wanes and more infected indi-
viduals become symptomatic.8 Although the prevalence of
asymptomatic parasitemia may decrease as transmission
declines, most infected individuals are asymptomatic even in
low transmission settings.4,6,7 However, there is large varia-
tion in the prevalence of asymptomatic parasitemia even in
settings with similarly low transmission. The use of different
deﬁnitions of asymptomaticmalaria and diagnostic testsmay,
in part, explain this heterogeneity.4
Routinely used diagnostic tools, such as microscopy and
RDTs, are not sufﬁciently sensitive to detect low parasite
levels typically found in asymptomatic individuals (< 100
parasite/μL).7 The use of more sensitive tests such as poly-
merase chain reaction (PCR) can more accurately estimate
parasite prevalence and characterize asymptomatic individ-
uals with low-level parasitemia, such as those who are RDT
negative but PCRpositive (deﬁnedhere as subpatentmalaria).
Numerous studies have compared microscopy and PCR
results to characterize the extent of submicroscopic
malaria.6,9,10 However, few studies have directly compared
RDT and PCR results, and the magnitude of asymptomatic,
subpatent, and infectious parasitemia in pre-elimination set-
tings remains poorly understood. The primary objective of this
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study was to investigate the prevalence of subpatent and
asymptomatic Plasmodium falciparum infection and game-
tocytemia in the catchment area of Macha Hospital, Southern
Province, Zambia, where malaria transmission has declined
more than 90% since 2000.11,12 Zambia has adopted the goal
of achieving malaria elimination by 2021, and Southern
Province is one of the regions that has been the focus of
recent operational strategies for malaria elimination.13 Un-
derstanding characteristics of individuals with subpatent and
asymptomatic parasitemia will help guide these elimination
strategies.
METHODS
Study site. The studywas conducted in the catchment area
of Macha Hospital, a rural settlement in Southern Province,
Zambia. The study area lies about 1,100 meters above sea
level and 70 km from the nearest town of Choma. The climate
is tropical savannah, with distinct wet and dry seasons.
Malaria transmission is highest during the single rainy season
from November to April, and the primary vector is Anopheles
arabiensis.11,14 Subsistence farming and animal rearing are
the primary sources of livelihood. Most residents live with
extended family in scattered households comprising one or
more structures.
Sampling and data collection. The study design and
procedures were described previously.12 Brieﬂy, satellite im-
ages of the catchment area were used to create a sampling
frame from which households were randomly selected for
participation in community-based, serial cross-sectional
surveys. Trained local ﬁeld workers used global positioning
system coordinates to locate selected households for initial
notiﬁcation visits and data collection. All household residents
present at the time of the visit were eligible for enrollment, and
written informed consent was obtained from all adults or
caregivers of children who agreed to participate. Question-
naires were administered to collect information on age, gen-
der, recent history of malaria, signs and symptoms of malaria,
and recent antimalarial therapy. Self-reported history of
malaria included the occurrence of fever, headache, chills,
vomiting, diarrhea, andcoughwithin theprior 48 hours and the
prior 2 weeks. For recent antimalarial drug use, surveys con-
ducted from 2008 to 2011 used a 2-week reference period,
whereas surveys thereafter used a 1-month reference period
to better identify individuals with potential prolonged
P. falciparum histidine-rich protein 2 (PfHRP2) antigenemia
following treatment. Body temperature on the date of as-
sessment was recorded using a digital ear thermometer
(ThermoScan®, Braun, Kronberg, Germany), and a tempera-
ture equal to or greater than 38C was considered fever.
Laboratory procedures. Blood samples were collected by
ﬁnger prick and screened for malaria using a PfHRP2-based
RDT (ICT Malaria P.f.; ICT Diagnostics, Cape Town, South
Africa). In 2013, the Zambian Ministry of Health switched to
another PfHRP2-based RDT, the SD Bioline Malaria Ag P.f.
(Standard Diagnostics, Inc., Gyeonggi-do, Republic of Korea)
as the standard RDT. Both RDTs met World Health Organi-
zation procurement criteria and reliably detected parasite
densities of 200 parasites/μL or higher.15 In accordancewith
the national guidelines, RDT-positive individuals were
treated with artemether/lumefantrine, whereas pregnant
RDT-positive women were referred to local health centers for
treatment with quinine in the ﬁrst trimester and ACT in the
second and third trimesters. Finger prick blood samples were
also used to prepare blood smears formicroscopic examination
and dried blood spots (DBS) on ﬁlter paper (Whatman 903™
Protein Saver Card; GE Healthcare Bio-Sciences, Pittsburgh,
PA). Blood smears were Giemsa-stained and independently
examinedby twomicroscopists.Whenmicroscopy resultswere
discordant, a third reader examined the slide to make the ﬁnal
determination.Bloodspotsweredriedovernight and individually
stored in a Ziploc bagwith a desiccant at −20C. Approximately
50 μL of dried blood was excised and used for each molecular
assay for asexual and sexual stages of P. falciparum.
Parasite DNA was extracted from the DBS using a Chelex-
saponin method as previously described.16 Nested PCR was
used to detect the presence of Plasmodium mitochondrial
DNAusing genus-speciﬁc primers targeting the cytochrome b
(cytb) gene.12,17 The detection limit of the genus-speciﬁc PCR
was 1 parasite/μL. Polymerase chain reaction–, RDT- or
microscopy-positive samples were re-analyzed at the Johns
Hopkins Bloomberg School of Public Health for species
conﬁrmation and determination of parasite densities. Quan-
titative PCR (q-PCR) was performed using SYBR® Green su-
per mix (Bio-Rad, Hercules, CA) and reactions were run in a
CFX384 real time thermo cycler (Bio-Rad). Species-speciﬁc
primers targeting the cytbgene, and thermocycling conditions
were described.12 The limit of detection for the P. falciparum
cytb q-PCR was 0.04 copies/μL.12 To detect P. falciparum
gametocytes, RNA was extracted from the DBS, cDNA was
made by reverse transcriptase, and a nested PCR was per-
formed to amplify cDNA to detect pfs25 transcripts.18 Samples
from 2008 to 2009 were analyzed to detect gametocytes re-
gardless of PCR status; however, because of the low parasite
prevalence, only PCR-positive samples were analyzed by re-
verse transcriptase-PCR (RT-PCR) for samples collected from
2010 to 2013. The limit of detection for the pfs25 RT-PCR was
10gametocyte/μL.AssayswereperformedatMachaResearch
Trust in Zambia except species conﬁrmation by q-PCR.
Statistical analysis. Participants who reported antimalarial
drug use within the prior month were excluded as they were
more likely to be asymptomatic yet test positive by RDT be-
cause of residual antigenemia.19,20 To establish criteria for
asymptomatic malaria, signs and symptoms that were more
prevalent among RDT-positive individuals were identiﬁed
using the χ2 test for proportions.
To assess factors associated with subpatent parasitemia
comparedwith uninfected individuals, including demographic
characteristics (age and gender), individual characteristics
(signs and symptoms of malaria and reported bed net use),
household characteristics (presence of children younger than
5 years and RDT-positive household residents) and season-
ality, the χ2 test for proportionswas applied and Fisher’s exact
test was used when sample sizes were fewer than ﬁve ob-
servations. Variables associated with the outcome with a P
value £ 0.2 were included in a logistic regression model and
tested by stepwise regression. Variables with P < 0.05 were
included in the ﬁnal model.
To identify characteristics of individuals with subpatent
parasitemia, and thus missed by current RDTs, individuals
with subpatent parasitemia were compared with those who
had parasitemia conﬁrmed by both RDT and PCR by age (di-
chotomized as younger or older than 15 years), gender,
symptomsofmalaria, andpresence of gametocytemia. The χ2
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test for proportions was applied and Fisher’s exact test was
used when sample sizes were fewer than ﬁve observations.
Statistical analyses were performed using Stata version 14
(StataCorp LP, College Station, TX).
Ethical considerations. The study was approved by the
Johns Hopkins Bloomberg School of Public Health In-
stitutional Review Board and the Zambian Tropical Diseases
Research Center Ethics Research Committee.
RESULTS
Characteristics of study participants. Between February
2008 and November 2013, 4,204 participants were enrolled in
the community-based, serial cross-sectional surveys. Ex-
cluded from analysis were those with 1) incomplete data on
demographic characteristics, self-reported malaria history,
temperature on the day of the study visit, and RDT results (N =
110); 2) reported antimalarial drug use within the prior month
(N = 73); 3)Plasmodiummalariaemonoinfection (N = 2); and 4)
missing PCR results (N = 156). The remaining 3,863 (92%)
participants were included in the ﬁnal analysis (Figure 1).
Of the 73 participants who reported taking antimalarial drugs
within thepriormonth, 76%reportedat least one symptom (fever,
chills, headache,diarrhea, vomiting,orcough) in thepast2weeks,
and thisproportionwassigniﬁcantlyhigher than thosewhodidnot
report taking an antimalarial drug (53%, P < 0.005). All 73 partic-
ipants who reported antimalarial use within the prior month had
RDT andmicroscopy results, 69 had genus-speciﬁc nested PCR
results, and 35 had gametocyte RT-PCR results available. Test
positivity was 1.4% by microscopy, 2.7% by RDT, 2.9% by
genus-speciﬁc nested PCR, and 2.9% by gametocyte RT-PCR.
Approximately half of the participants were male (47%) and
about half were aged 15 years or younger (51%) (Supplemental
Table 1), consistent with the age distribution of the general
population inZambia.21Test positivitywas1.8%byPCR, 1.4%
byRDTand0.2%bymicroscopy.Sevenpercent of households
had at least one RDT-positive resident. On the day of the
study visit, 1.5% of participants had documented fever
(tympanic temperature ³ 38C). The most prevalent self-
reported symptoms were cough and headache within either
the prior 48 hours or 2 weeks (Supplemental Table 1). Sixty-
two percent of households reported owning at least one
bed net.
Parasite densities. Of the 102 microscopy-, RDT- or
genus-speciﬁc PCR–positive samples, 87 were tested by
pfcytb q-PCR to determine the parasite density and 61 (70%
of 87) were q-PCR positive. Based on the q-PCR results, the
median parasite density was 2 parasites/μL, suggesting most
parasitemic individuals had low-level parasitemia (Figure 2).
Most (89%) infected individuals also had submicroscopic
parasitemia. Some individualswith low-level parasitemiawere
RDT positive, but more than half (58%) of individuals with
parasitemia less than the median parasite density were RDT
negative (Figure 2).
Of the 61 samples with q-PCR results, 59 had gametocyte-
speciﬁc pfs25 RT-PCR data available, 18 of which had de-
tectable gametocyte-speciﬁcmRNA (31%of 59). Of the seven
microscopy-positive samples, two had detectable gametocyte
mRNA. Although the sample size was small, most individuals
with detectable gametocyte mRNA had submicroscopic and
subpatent parasitemia (Figure 3).
Characteristics of symptomatic and asymptomatic
parasitemia. To identify signs and symptoms associatedwith
malaria conﬁrmed by RDT, 4,019 participants with data on
RDT status and complete demographic information, self-
reported malaria history, and temperature on the day of the
visit were included (Figure 1). Among these, 56 (1.4%) were
RDT positive. Rapid diagnostic test–positive individuals were
more likely to be aged 5–25 years and less likely to be younger
than5yearsorolder than25years than individualswhowereRDT
negative (P = 0.001) (Supplemental Table 2). Rapid diagnostic
test–positive individualswere alsomore likely to have fever on the
dayof thestudyvisit (P<0.0005) andself-reported fever (P=0.03)
and chills (P = 0.02) within the previous 48 hours (Supplemental
Table 2). Based on these results, symptomatic malaria was de-
ﬁned as individuals with conﬁrmed P. falciparum infection by mi-
croscopy, RDT, or PCR with documented fever or self-reported
feverwithchillswithin theprior48hours.Approximately two-thirds
(64%) of RDT-positive participantswere asymptomatic using this
deﬁnition.
Are individuals with subpatent parasitemia different
from those without parasitemia? Forty-eight individuals
with subpatent parasitemia were compared with 3,761 indi-
viduals without evidence of parasitemia (Table 1). A higher
proportion of individuals with subpatent parasitemia were
aged 5–25 years compared with individuals without para-
sitemia (71% versus 47%, P = 0.001). Most individuals with
subpatent parasitemia were asymptomatic, and the preva-
lence of fever or malaria-speciﬁc symptoms (fever on the day
of the visit or self-reported fever with chills in the last 48 hours)
was not signiﬁcantly different from those without parasitemia
(afebrile: 97% versus 99%, P = 0.10; absence of malaria-
speciﬁc symptoms: 85% versus 90%, P = 0.35). The preva-
lence of subpatent parasitemia did not vary by season. In
the ﬁnal logistic regression model, the odds of subpatent
FIGURE 1. Flowchart showing the selection of participants included
in the analysis (A) and contingency table of rapid diagnostic test (RDT)
and polymerase chain reaction (PCR) results (B).
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parasitemia was signiﬁcantly higher for participants who were
aged 5–15 years (odds ratio [OR] = 7.3 [95% conﬁdence in-
terval [CI]: 1.7, 31],P = 0.007) and 15–25 years (OR = 9.2 [95%
CI: 2.1, 41], P = 0.004) compared with children younger than
5 years, adjusting for gender, household bed net ownership,
and households with at least one RDT-positive resident.
Are individuals with subpatent parasitemia different
from those who are RDT positive? Twenty individuals with
parasitemia by RDT and 48 with subpatent parasitemia were
compared (Table 2). Of the 48 individuals with subpatent
parasitemia, two had parasites observed by microscopy, but
the level of parasitemia was less than 200 parasites/μL, the
reported limit of detection for the RDT. Because of the small
sample size, age was dichotomized as younger or older than
15 years. Individuals with parasitemia by RDTweremore likely
to report malaria-speciﬁc symptoms than those with sub-
patent parasitemia (45% versus 15%, P = 0.01). A higher
proportion of individuals with subpatent parasitemia were
older than 15 years (52%versus 25%,P= 0.06). Importantly, a
higher proportion of individuals with parasitemia by RDT had
detectable gametocytemia (50% versus 27%, P = 0.09), but
approximately one-quarter of individuals with subpatent par-
asitemia haddetectable gametocyte-speciﬁcmRNA (Table 2).
Of the 34 RDT-positive but PCR-negative samples (Figure 1),
27 (79%) were tested for gametocyte-speciﬁc mRNA and all
were negative (0% [one-sided, 97.5% CI: 0, 0.13]).
DISCUSSION
Because of their low cost and ease of use, requiringminimal
training and equipment, RDTs are widely used as diagnostics
FIGURE 2. Parasite density distribution and detection of parasitemia by (A) microscopy or (B) rapid diagnostic test (RDT). Parasite densities
quantiﬁed by pfcytb q-PCR are presented in log10 scale. All q-PCR–positive samples were included regardless of symptomatic or asymptomatic
status (N = 61).
FIGURE 3. Parasite density distribution and detection of gameto-
cyte-speciﬁc mRNA by reverse transcriptase polymerase chain re-
action (RT-PCR). Of those pfcytb Quantitative PCR (q-PCR)–positive
samples, 59 were tested for the detection of gametocyte-speciﬁc
mRNA.
TABLE 1
Characteristics of individuals with subpatent parasitemia (RDT
negative but PCR positive) and those without parasitemia
RDT
negative
but PCR
positive
(N = 48)
RDT and PCR
negative
(N = 3,761)
N % N % P value
Male 28 58 1,753 47 0.11
Age 0.001
< 5 years 2 4.2 783 21 –
5–15 years 21 44 1,160 31 –
15–25 years 13 27 584 16 –
> 25 years 12 25 1,234 32 –
At least one child younger than
5 years in the household
34 71 2,836 75 0.47
Presence of bed nets in the house
where sleeping
24 50 2,323 62 0.10
At least one RDT-positive
household member
5 10 219 5.8 0.20
Absence of fever on the day of
the visit
46 96 3,710 99 0.10
Absence of malaria-speciﬁc
symptoms
41 85 3,368 90 0.35
Seasonality
Rainy season (November–April) 25 52 1,951 52 0.98
Hotanddryseason (August–October) 10 21 657 17 0.54
Cool and dry season (May–July) 13 27 1,153 31 0.59
PCR = polymerase chain reaction; RDT = rapid diagnostic test.
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for malaria, improving patient care. More recently, their use
has extended beyond the clinical diagnosis of symptomatic
malaria. Rapid diagnostic test are increasingly used for active
surveillance in active or reactive test-and-treat programs.
Despite this expansion, more information is needed to opti-
mize such use and better understand their limitations in dif-
ferent epidemiological settings. In a low transmission setting
in southern Zambia, individuals with subpatent parasitemia
were more likely to be older than uninfected individuals and
those with patent parasitemia conﬁrmed by both RDT and
PCR. The absence of clinical symptoms makes these indi-
viduals difﬁcult to identify. Although the prevalence of
gametocytemia was lower than in those with a positive RDT,
approximately one-quarter of individuals with subpatent
parasitemia had detectable gametocyte-speciﬁc mRNA,
suggesting these individuals potentially could transmit
P. falciparum parasites.
The prevalence and proportion of low-density parasitemia
reﬂects recent malaria transmission dynamics and the impact
of interventions.22 In southern Zambia, the prevalence of mi-
croscopicparasitemiawas low (0.2%),with 91%of individuals
with parasitemia by PCR having submicroscopic parasitemia.
The proportion of submicroscopic infections in southern
Zambia is consistent with that predicted by models of the
inverse relationship between the prevalence of parasitemia by
PCR and the proportion of submicroscopic infections.9 More
speciﬁcally, the study area experienced a decline in malaria
transmission over the past decade, and the high proportion of
submicroscopic infections is consistent with models that
suggest such high proportions can follow recent, large de-
creases in malaria transmission.9,22
In southern Zambia, characteristics of individuals with
subpatent parasitemia were similar to those without para-
sitemia except for their age distribution, with subpatent par-
asitemia more common among school-aged children and
young adults. In malaria-endemic areas, most clinical cases
occur among children younger than 5 years. Age is a proxy for
malaria exposure and older individuals are more likely to have
developed premunition, or clinical immunity. In the highlands
of western Kenya, PCR-conﬁrmed, parasitemic individuals
older than 20 years had reduced odds of RDT-conﬁrmed in-
fection, whereas children younger than 5 years were more
likely to be RDT and PCR positive.23,24 A recent pooled anal-
ysis of published and unpublished studies on the relationships
betweenRDT andPCRpositivity across settingswith different
malaria endemicity showed that the odds of subpatent in-
fection in adults was 5-fold higher than those younger than
5 years, even after adjusting for transmission intensity.25
School-age children traditionally have not been a focus of
malaria control programs, but more recent data suggest that
this age group has high parasite prevalence and can harbor
gametocytes.26 Despite their high risk of parasitemia, low bed
net use among school-age children has been widely
reported.27–29 Low bed net use among school-age children
was previously observed in southern Zambia, perhaps con-
tributing to the high parasite prevalence in this age group.30,31
A small proportion (4%) of individuals with subpatent par-
asitemia had fever on the day of the study visit and 15% had
malaria-speciﬁc symptoms. However, the prevalence of fever
and symptoms was not signiﬁcantly different from individuals
without parasitemia, consistent with previous ﬁndings that
low-density parasitemia can be associated with fever but not
more frequently than those without parasitemia.32
Compared with individuals with patent, RDT-positive par-
asitemia, individuals with subpatent parasitemia were more
likely to be older and asymptomatic. Infected individuals with
subpatent parasitemia will not be detected through active or
reactive test-and-treat programs that rely on RDTs as the di-
agnostic test. Plasmodium falciparum histidine-rich protein 2
deletions have been reported in sub-Saharan Africa,33–38 and
parasites with Pfhrp2 deletions can result in RDT-negative
parasitemia. We have not identiﬁed Pfhrp2 deletions in
southern Zambia and RDT-negative parasitemia is likely due
to low-level parasitemia, less than the limit of detection of
RDTs.12 Importantly, approximately one-quarter of individuals
with subpatent parasitemia had detectable gametocyte-
speciﬁc mRNA, highlighting their potential contribution to
malaria transmission.
Further complicating the interpretation of RDT results when
used for active or reactive casedetection in a low transmission
setting was the fact that more than half of RDT-positive par-
ticipants were PCR negative, consistent with false-positive
RDT results due to persistent antigenemia after clearance of
parasites.19 Importantly, among individuals with a positive
RDTbut negativePCR forP. falciparumwhohadRT-PCRdata
available, none had detectable gametocyte-speciﬁc mRNA,
suggesting that these individuals were not at risk of trans-
mitting parasites and thus do not need to be identiﬁed and
treated through active or reactive test-and-treat programs. As
the storage conditions of ﬁlter papers and the duration of
storage can affect the efﬁciency of RNA extraction,39 some of
the samples negative by RT-PCR could be misclassiﬁed.
Nevertheless, detectable gametocytemia amongRDT-positive
but PCR-negative individuals is unlikely.
One limitation of this study was the small number of indi-
viduals with parasitemia, a problem common to studies in low
transmission settings. However, understanding the charac-
teristics of the parasite reservoir in settings with low parasite
prevalence is critical to the design of effective and efﬁcient
elimination strategies. A second limitation was imperfect as-
sessment of the infectiousness of individuals with subpatent
parasitemia and detectable gametocyte-speciﬁc mRNA, and
their role in sustaining transmission in this low transmission
setting. Individuals with higher gametocyte burden are more
infectious to mosquitoes,40 but further study of the in-
fectiousness of individuals with subpatent parasitemia in this
setting will be important to guide elimination strategies.
The high prevalence of asymptomatic and subpatent par-
asitemia in this area of declining malaria transmission in
TABLE 2
Characteristics of individuals with subpatent parasitemia (RDT neg-
ative but PCR positive) and those with patent parasitemia
RDT
and PCR
positive
(N = 20)
RDT
negative
but PCR
positive
(N = 48)
N % N % P value
Younger than 15 years 15 75 23 48 0.06
Male 8 40 28 58 0.19
Presence of fever on the day of the visit 6 30 2 4.2 0.01
Presence of malaria-speciﬁc symptoms 9 45 7 15 0.01
Gametocytes by RT-PCR 10 50 13 27 0.09
PCR = polymerase chain reaction; RDT = rapid diagnostic test; RT-PCR = reverse
transcriptase PCR.
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southern Zambia presents signiﬁcant challenges to malaria
elimination. Strategies based on active or reactive case de-
tection are important to identify asymptomatic, infected indi-
viduals but more sensitive screening tools or focal drug
administration strategies may be needed to further reduce
malaria transmission and achieve elimination.
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